Sentynl
1 known investors
Sentynl Therapeutics is a pharmaceutical company that develops and commercializes prescription therapies, including ZYCUBO (copper histidinate), which has received FDA approval. It provides access, support, and medical affairs services for its products.
BiotechHealthtech
Investors · 1
Frequently asked questions
- What does Sentynl do?
- Sentynl Therapeutics is a pharmaceutical company that develops and commercializes prescription therapies, including ZYCUBO (copper histidinate), which has received FDA approval. It provides access, support, and medical affairs services for its products.
- Who are Sentynl's investors?
- Sentynl's investors include Avego BioScience Capital.